Androgen suppression and clinical improvement with dopamine agonists in hyperandrogenic-hyperprolactinemic women

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 46, Issue 7, 2001, Pages 678-684

  Hagag, P ^a   Hertzianu, I ^a   Ben Shlomo, A ^a   Weiss, M ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Androgens; Hirsutism, acne, dopamine agonists, dehydroepiandrosterone sulfate; Hyperprolactinemia

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE;

ACNE; ADULT; ANDROGEN SYNTHESIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROLACTINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANDROGENS; DOPAMINE AGONISTS; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; HYPERPROLACTINEMIA; MAGNETIC RESONANCE IMAGING; PROLACTIN; RADIOIMMUNOASSAY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034904324     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clinical presentation of hyperprolactinemia
2. Prolactin and adrenal androgen secretion
3. Prolactin modulation of DHEAS secretion
4. Multiple androgenic abnormalities including elevated freetestosterone in hyperprolactlnemic women
5. Effect of hyperprolactinemia on the androgen response to an oral glucose load
6. Adrenal androgens in patients with chronic marked elevation of prolactin
7. Lack of effect of prolactin secretion on plasma dehydroepiandrosterone sulfate
8. Adrenal androgen production in hyperprolactinemic states
9. Adrenal dysfunction and hirsutism
10. Endocrinological and clinical analysis of hyperprolactinemic patients with and without ultrasonically diagnosed polycystic ovarian changes
11. Prevalence of hyperprolactinemia in 172 consecutive female patients with hirsutism
12. Hyperprolactinemia induced by cyproterone acetate in human subjects
13. Prolactin and its disorders
14. Hirsutism, alopecia and acne
15. The effectiveness of acne treatment: An assessment by patients of the outcome of therapy
16. Contribution to the problem of hyperprolactinemia: Experience with 4199 prolactin assays and 117 prolactinomas
17. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
18. Normalization of androgen and sex hormone-binding globulin levels after treatment of hyperprolactinemia
19. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects
20. The chronic administration of cabergolide normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome
21. Physiologic hair growth
22. Androgen excess in cystic acne
23. Adrenarche
24. Synthesis and metabolism of corticosteroids
25. Adrenarche results from development of a 3β hydroxysteroid dehydrogenase-deficient adrenal reticularis
26. Prolactin has a direct effect on adrenal androgen secretion
27. Is 11-beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
28. Adrenal excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis
29. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia
30. In situ hybridization of estrogen receptor mRNA in human adeno hypophyseal cells and pituitary adenomas
31. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia
32. Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia
33. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status
34. Regulation of parathyroid hormone-related protein gene expression in human endometrial stroma cells in culture
35. Neuroleptic-associated hyperprolactinemia: Can it be treated with bromocriptine?
36. Serum prolactin concentrations in patients taking neuroleptic drugs